| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance | Clinical Microbiology and Infection | 2012 | 9,616 |
| 2 | Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis | Clinical Microbiology and Infection | 2020 | 1,118 |
| 3 | Evolving epidemiology of hepatitis C virus | Clinical Microbiology and Infection | 2011 | 1,107 |
| 4 | Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline | Clinical Microbiology and Infection | 2018 | 1,015 |
| 5 | ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients | Clinical Microbiology and Infection | 2012 | 998 |
| 6 | European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection | Clinical Microbiology and Infection | 2014 | 945 |
| 7 | Microbial culturomics: paradigm shift in the human gut microbiome study | Clinical Microbiology and Infection | 2012 | 935 |
| 8 | COVID-19, SARS and MERS: are they closely related? | Clinical Microbiology and Infection | 2020 | 880 |
| 9 | Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology | Clinical Microbiology and Infection | 2006 | 847 |
| 10 | Toxoplasma gondii: transmission, diagnosis and prevention | Clinical Microbiology and Infection | 2002 | 832 |
| 11 | Guidelines for the management of adult lower respiratory tract infections - Full version | Clinical Microbiology and Infection | 2011 | 753 |
| 12 | Emergence of Clostridium difficile-associated disease in North America and Europe | Clinical Microbiology and Infection | 2006 | 744 |
| 13 | Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe | Clinical Microbiology and Infection | 2012 | 742 |
| 14 | Guidelines for the validation and application of typing methods for use in bacterial epidemiology | Clinical Microbiology and Infection | 2007 | 679 |
| 15 | Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study | Clinical Microbiology and Infection | 2021 | 677 |
| 16 | The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports | Clinical Microbiology and Infection | 2019 | 676 |
| 17 | ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients | Clinical Microbiology and Infection | 2014 | 663 |
| 18 | Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories | Clinical Microbiology and Infection | 2008 | 652 |
| 19 | Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review | Clinical Microbiology and Infection | 2022 | 644 |
| 20 | Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains | Clinical Microbiology and Infection | 2011 | 613 |
| 21 | The negative impact of antibiotic resistance | Clinical Microbiology and Infection | 2016 | 608 |
| 22 | Listeriosis: a resurgent foodborne infection | Clinical Microbiology and Infection | 2010 | 600 |
| 23 | Real-time PCR in the microbiology laboratory | Clinical Microbiology and Infection | 2004 | 596 |
| 24 | Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007 | Clinical Microbiology and Infection | 2011 | 589 |
| 25 | ESCMID guideline: diagnosis and treatment of acute bacterial meningitis | Clinical Microbiology and Infection | 2016 | 587 |
| 26 | Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution | Clinical Microbiology and Infection | 2000 | 582 |
| 27 | ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014 | Clinical Microbiology and Infection | 2015 | 582 |
| 28 | Follow-up of adults with noncritical COVID-19 two months after symptom onset | Clinical Microbiology and Infection | 2021 | 576 |
| 29 | Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis | Clinical Microbiology and Infection | 2021 | 571 |
| 30 | The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide | Clinical Microbiology and Infection | 2014 | 561 |
| 31 | ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013 | Clinical Microbiology and Infection | 2014 | 560 |
| 32 | Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories | Clinical Microbiology and Infection | 2014 | 560 |
| 33 | Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective | Clinical Microbiology and Infection | 2012 | 555 |
| 34 | EUCAST expert rules in antimicrobial susceptibility testing | Clinical Microbiology and Infection | 2013 | 555 |
| 35 | Emerging carbapenemases in Gram-negative aerobes | Clinical Microbiology and Infection | 2002 | 548 |
| 36 | Global trends in the distribution of Candida species causing candidemia | Clinical Microbiology and Infection | 2014 | 541 |
| 37 | Rapid spread of emerging Zika virus in the Pacific area | Clinical Microbiology and Infection | 2014 | 539 |
| 38 | Relationship between periodontal infections and systemic disease | Clinical Microbiology and Infection | 2007 | 536 |
| 39 | The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses | Clinical Microbiology and Infection | 2014 | 530 |
| 40 | Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China | Clinical Microbiology and Infection | 2020 | 523 |
| 41 | Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study | Clinical Microbiology and Infection | 2021 | 523 |
| 42 | Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting | Clinical Microbiology and Infection | 2020 | 514 |
| 43 | Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe | Clinical Microbiology and Infection | 2013 | 505 |
| 44 | Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe | Clinical Microbiology and Infection | 2008 | 501 |
| 45 | Infections due to emerging and uncommon medically important fungal pathogens | Clinical Microbiology and Infection | 2004 | 495 |
| 46 | What is antimicrobial stewardship? | Clinical Microbiology and Infection | 2017 | 494 |
| 47 | Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe | Clinical Microbiology and Infection | 2011 | 492 |
| 48 | Efflux-mediated multiresistance in Gram-negative bacteria | Clinical Microbiology and Infection | 2004 | 482 |
| 49 | Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment | Clinical Microbiology and Infection | 2004 | 463 |
| 50 | Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay | Clinical Microbiology and Infection | 2020 | 463 |
